Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.430
+0.060 (2.53%)
Oct 10, 2025, 2:40 PM EDT - Market open

Oramed Pharmaceuticals Revenue

Oramed Pharmaceuticals had revenue of $2.00M in the twelve months ending June 30, 2025.

Revenue (ttm)
$2.00M
Revenue Growth
n/a
P/S Ratio
48.73
Revenue / Employee
$500,000
Employees
4
Market Cap
99.64M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 20231.34M-1.36M-50.43%
Dec 31, 20222.70M-9.00K-0.33%
Dec 31, 20212.71M9.00K0.33%
Aug 31, 20212.70M-9.00K-0.33%
Dec 31, 2020 Pro Pro Pro
Aug 31, 2020 Pro Pro Pro
Aug 31, 2019 Pro Pro Pro
Aug 31, 2018 Pro Pro Pro
Aug 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group422.82B
Johnson & Johnson90.63B
Merck & Co.63.62B
AbbVie58.33B
AstraZeneca56.50B
Novartis AG55.19B
Eli Lilly and Company53.26B
Novo Nordisk49.11B
Revenue Rankings